Archive for April, 2011
« Previous Entries Next Entries »Run brings community closer – Bennington Banner
Friday, April 29th, 2011
Run brings community closerBennington BannerKeenan was recently diagnosed with amyotrophic lateral sclerosis, better known as Lou Gehrig's Disease. ALS affects the central nervous system. It is a neurodisease that starts when neurons in the brain start to degenerate. …and more »
RXi Pharmaceuticals and the University of Massachusetts Medical School … – PharmaLive.com (press release)
Friday, April 29th, 2011RXi Pharmaceuticals and the University of Massachusetts Medical School …PharmaLive.com (press release)The Center awarded the grant to contribute funding to an ongoing collaboration between UMMS and RXi Pharmaceuticals to develop a new treatment for ALS (amyotrophic lateral sclerosis) using RXI's proprietary self-delivering RNAi therapeutic platform …
Former pro wrestler speaks on concussions to packed house in Swampscott – Wicked Local
Thursday, April 28th, 2011Former pro wrestler speaks on concussions to packed house in SwampscottWicked Local… on stage to talk about his career in the NFL, the concussions he sustained while playing football, and his battle with Amyotrophic lateral sclerosis (ALS), a disease Turner believes he contracted as a direct result from years of blows to the head. …and [...]
Wellesley High hosting charity basketball game for ALS research – Boston Globe
Thursday, April 28th, 2011Wellesley High hosting charity basketball game for ALS researchBoston GlobeWellesley High School student athletes are running a charity basketball game Friday to raise awareness of Amyotrophic lateral sclerosis or Lou Gehrig's disease after the school's junior varsity boys basketball coach Paul Seaver, was diagnosed with the …
Marine battles Lou Gehrig’s disease – The Auburn Plainsman
Thursday, April 28th, 2011Marine battles Lou Gehrig's diseaseThe Auburn PlainsmanHogg became known for fighting as a Marine in the Iraq War, but today he is fighting against amyotrophic lateral sclerosis, also known as Lou Gehrig's disease. ALS is a disease of the nerve cells in the brain and spinal cord that control voluntary …
Rxi secures SBIR grants to develop novel RNAi therapeutics for ALS – News-Medical.net
Thursday, April 28th, 2011Rxi secures SBIR grants to develop novel RNAi therapeutics for ALSNews-Medical.net… of the Department of Neurology at the University of Massachusetts Medical School in Worcester that is focused on the preclinical development of novel RNAi therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders. …and more »
Gene Mutations Linked to ALS – MedIndia
Thursday, April 28th, 2011MedIndia Gene Mutations Linked to ALSMedIndiaBrandeis researchers have successfully reversed the toxicity of the mutated FUS/TLS protein in amyotrophic lateral sclerosis. People with one of those mutant genes are more likely to develop the disease …
How social media can help with clinical trials – SmartPlanet.com (blog)
Thursday, April 28th, 2011How social media can help with clinical trialsSmartPlanet.com (blog)In a recent example, a social networking health site called PatientsLikeMe, focused on patients and research tapped the so-called hive-mind to see how lithium affected the progression of amyotrophic lateral sclerosis (ALS). …and more »
UCSF’s Olney Driven to Publish Clinical Finding Even as ALS Takes its Toll – UCSF News Services
Thursday, April 28th, 2011UCSF News Services UCSF's Olney Driven to Publish Clinical Finding Even as ALS Takes its TollUCSF News ServicesBy Jennifer O'Brien on April 27, 2011 In 2004, Richard K. Olney, MD, the founding director of the ALS Treatment and Research Center at UCSF and a pioneer in ALS clinical research, was himself diagnosed with amyotrophic lateral [...]
Cytokinetics, Incorporated Reports First Quarter 2011 Financial Results – Marketwire (press release)
Wednesday, April 27th, 2011Cytokinetics, Incorporated Reports First Quarter 2011 Financial ResultsMarketwire (press release)In April, Cytokinetics presented data from its Phase IIa Evidence of Effect (EoE) clinical trial of CK-2017357 in amyotrophic lateral sclerosis (ALS) patients at the 63 rd Annual Meeting of the American Academy of Neurology. …
« Previous Entries Next Entries »